Why the Market Is So Bullish About Trillium Therapeutics
Shares of Trillium Therapeutics (NASDAQ: TRIL) skyrocketed last year. After selling for $1.17 on the first trade in January, the shares clocked out at $14.71 on the last trade in December. This amazing run made Trillium a 13-bagger, and one of the strongest performers in the healthcare space in 2020. What caused this magnificent run?
In this clip from Motley Fool Live, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Taylor Carmichael discuss Trillium. The segment was recorded on Jan. 15, 2021.
Source Fool.com
